期刊文献+

沙美特罗/丙酸氟替卡松与温针灸对慢性阻塞性肺疾病稳定期肺功能及临床疗效影响的比较研究 被引量:4

Comparative research on affections of lung function and clinical curative by treatments of salmeterol/ fluticasone propionate and warm needing method on treating stationary chronic obstructive pulmonary disease
原文传递
导出
摘要 目的研究沙美特罗/丙酸氟替卡松与温针灸对慢性阻塞性肺疾病(COPD)稳定期肺功能的影响,观察其临床疗效和对临床症状改善的作用。方法将63例人选病例按照随机数字表分为沙美特罗/丙酸氟替卡松组和温针灸组各31例和32例,除去研究过程中的脱落病例,最终两组各完成30例和29例,按设计的治疗方案进行治疗,观察两组病例治疗后的第1秒用力呼气容积(FEV1)等肺功能改变、临床症状的评分和呼吸等生命质量的评价,进行组间和组内的比较。结果两组均有效的改善了FEV。1、FEV1/FVC、FEV1占预计值%等肺功能(P〈O.05或P〈0.01),提高了生活质量,沙美特罗/丙酸氟替卡松对缓解呼吸道症状快捷有效,温针灸对患者寒热等全身症状作用持久有效。两组的临床显效率、总体有效率各为40.。O%、86.67%和17.24%、86.21%,两者总有效率相当(P〉0.05),但沙美特罗/丙酸氟替卡松组具有良好的临床显效率(P〈O.05)。结论沙美特罗/丙酸氟替卡松和温针灸均能起到改善COPD稳定期患者肺功能的作用,沙美特罗/丙酸氟替卡松的作用快捷,而温针灸的作用持久。 Objective To research the affection of lung function by seretide and warm needing method to stationary chronic obstructive pulmonary disease (COPD) and observe the clinical curative and the effect on improve the clinical symptoms. Methods 63 cases were divided into a seretide group with 31 cases and a warm needing group with 32 cases according to the random number table and finished 30 cases and 29 cases respectively after removed off cases. Observed changes of lung functions as FEV1 , evaluated the life quality,and scores of clinical symptoms and did comparisons among and in groups after treated by designed plan. Results Lung functions as FEV1, FEV1/FVC, FEV1 0~ pred were both improved in two groups( P 〈0.05 or P〈0.01), increased the life quality seretide released respiratory symptoms swiftly and effectively and warm needing was effect to whole symptoms as warm and cold. The clinical excellent rate was 40.00%, 17.24G and the total effective rate was 86.67%,86.21% respectively and the tolal effective rate was fairly( P 〉0.05), but seretide group had a better clinical excellent rate( P 〈0.05). Conclusions Both seretide and warm needing were effect to improve the lung function of patients with stationary COPD and the effect of seretide was swiftly and warm needing was lasting.
出处 《国际呼吸杂志》 2011年第11期839-842,共4页 International Journal of Respiration
关键词 慢性阻塞性肺疾病 沙美特罗/丙酸氟替卡松 温针灸 肺功能试验 圣·乔治呼吸问卷 Chronic obstructive pulmonary disease Salmeterol/fluticasone propionate Warmneeding Lung function tests SGRQ
  • 相关文献

参考文献11

  • 1Zhong N, Wang C, Yao W, et obstructive pulmonary disease in based survey. Am J Respir Crit 760. al. Prevalence of chronic China: a large, population- Care Med, 2007, 176:753.
  • 2Rabe KF, Hurd S, Anzueto A,et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2007,176 : 532-555.
  • 3Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med, 2000,343: 1902-1909.
  • 4Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med,2008,359:1543 -1554.
  • 5Curtis JR, Patrik DL. The assessment of healeh status among patients with COPD. Eur Respir J Suppl, 2003,41.- 36s-45s.
  • 6慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 7Jones PW. Quality of life measurement for patients with disease of the airways. Thorax, 1991,46:676- 682.
  • 8Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention. GINA executive summary. Eur Respir J, 2008,31:143-178.
  • 9Lindberg A, Larsson LG, Ronmark E,et al. Decline in FEVI in relation to incident chronic obstructive pulmonary disease ina cohort with respiratory symptoms. COPD, 2007, 4:5 -13.
  • 10沈宁,姚婉贞,刘政,王筱宏,郝振婷,柳小芳.慢性阻塞性肺疾病患者深吸气量与生命质量的关系[J].中华结核和呼吸杂志,2010,33(4):261-264. 被引量:22

二级参考文献24

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2支气管哮喘诊断标准、临床分期和严重程度分级[J].疑难病杂志,2006,5(3):180-180. 被引量:76
  • 3慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8235
  • 4中华医学会呼吸分会.支气管哮喘的定义、诊断、严重度分级和疗效判定标准[J].中华结核和呼吸杂志,1993,16:5-5.
  • 5Diaz O,Villafranca C,Ghezzo H,et al.Role of inspiratory capacity on exercise tolerance in COPD patients with and without tidal expiratory flow limitation at rest.Eur Respir J,2000,16:269-275.
  • 6Matin JM,Carrizo SJ,Gascon M,et al.Inspiratory capacity,dynamic hyperinflation,breathlessness,and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2001,163:1395-1399.
  • 7Babe KF,Hurd S,Anzueto A,et al.Global strategy for the diagnosis,management,and prevention of chronic obstructive pulmonary disease:GOLD executive summary.Am J Respir Crit Care Med,2007,176:532-555.
  • 8Doll H,Miravitlles M Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease:a review of the literature.Pharmacoeconomics,2005,23:345-363.
  • 9Andenaes R,Moum T,Kalfoss MH,et al.Changes in health status,psychological distress,and quality of life in COPD patients after hospitalization.Qual Life Res,2006,15:249-257.
  • 10Stahl E,Lindberg A,Jansson SA,et al.Health-related quality of life is related to COPD disease severity.Health Qual Life Outcomes,2005,3:56.

共引文献8260

同被引文献131

引证文献4

二级引证文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部